tradingkey.logo
tradingkey.logo
검색

ICAD Inc

ICAD
관심 목록에 추가
3.870USD
0.0000.00%
종가 07/02, 13:00ET시세는 15분 지연됩니다
105.19M시가총액
손실P/E TTM

자세한 내용은 ICAD Inc 회사

iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a woman’s breast anatomy from the mammogram image.

ICAD Inc 정보

종목 코드 ICAD
회사 이름ICAD Inc
상장일Dec 13, 1984
CEOMs. Dana R. Brown
직원 수66
유형Ordinary Share
회계 연도 종료Dec 13
주소98 Spit Brook Rd Ste 100
도시NASHUA
증권 거래소Euronext Paris
국가United States of America
우편 번호03062-5737
전화16038825200
웹사이트https://www.icadmed.com/
종목 코드 ICAD
상장일Dec 13, 1984
CEOMs. Dana R. Brown

ICAD Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Eric Lonnqvist
Mr. Eric Lonnqvist
Chief Financial Officer
Chief Financial Officer
1.40K
-6.16%
Ms. Dana R. Brown
Ms. Dana R. Brown
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Michael John Doyle
Mr. Michael John Doyle
Independent Director
Independent Director
--
-100.00%
Mr. Andrew H. (Andy) Sassine
Mr. Andrew H. (Andy) Sassine
Independent Director
Independent Director
--
--
Dr. Rakesh Patel, M.D.
Dr. Rakesh Patel, M.D.
Independent Director
Independent Director
--
-100.00%
Mr. Mark Koeniguer
Mr. Mark Koeniguer
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Jonathan Go
Mr. Jonathan Go
Chief Technology Officer
Chief Technology Officer
--
-100.00%
Dr. Hedvig Hricak, M.D., Ph.D.
Dr. Hedvig Hricak, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Susan Alyson Wood, Ph.D.
Dr. Susan Alyson Wood, Ph.D.
Independent Director
Independent Director
--
-100.00%
John Nesbett
John Nesbett
Investor Relations
Investor Relations
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Eric Lonnqvist
Mr. Eric Lonnqvist
Chief Financial Officer
Chief Financial Officer
1.40K
-6.16%
Ms. Dana R. Brown
Ms. Dana R. Brown
Executive Chairman of the Board, President, Chief Executive Officer
Executive Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Michael John Doyle
Mr. Michael John Doyle
Independent Director
Independent Director
--
-100.00%
Mr. Andrew H. (Andy) Sassine
Mr. Andrew H. (Andy) Sassine
Independent Director
Independent Director
--
--
Dr. Rakesh Patel, M.D.
Dr. Rakesh Patel, M.D.
Independent Director
Independent Director
--
-100.00%
Mr. Mark Koeniguer
Mr. Mark Koeniguer
Chief Commercial Officer
Chief Commercial Officer
--
--

자주 묻는 질문

ICAD Inc의 상위 5대 주주는 누구인가요?

ICAD Inc의 상위 5대 주주는 다음과 같습니다: Mr. Eric Lonnqvist

ICAD Inc(ICAD)의 주식을 보유한 기관은 몇 개입니까?

2025Q2 기준으로, ICAD Inc의 주식을 보유한 기관은 총 117곳이며, 이들이 보유한 주식의 총 가치는 약 9.75M로 전체 발행 주식의 35.51%를 차지합니다. 이는 2025Q1 대비 1190732.00 증가한 수치입니다.

ICAD Inc의 최대 수익원은 무엇인가요?

2025Q2 기준, ICAD Inc의 Subscription term licenses 부문이 가장 높은 매출을 기록했으며, 금액은 1.78M로 전체 매출의 36.62%를 차지했습니다.